MHR Fund Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Iovance Biotherapeutics
IOVA
|
+$93.7M |
| 2 |
LGF.A
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
|
+$6.16M |
| 3 |
Madison Square Garden
MSGS
|
+$1.57M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 35.08% |
| 2 | Technology | 23.08% |
| 3 | Industrials | 20.93% |
| 4 | Healthcare | 13.16% |
| 5 | Financials | 7.39% |
Similar funds
MHR Fund Management's Q4 2022 Portfolio in Review
As of Q4 2022, MHR Fund Management held 30 positions worth $586M, up 10% from $532M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MHR Fund Management deployed $94.9M of net new capital in Q4 2022, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Iovance Biotherapeutics: 11,997,103 shares worth $76.7M.
By sector, the portfolio is most concentrated in Communication Services at 35% of assets, down from 48% a quarter earlier, followed by Technology and Industrials.
On the sell side, the most notable exit was EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant, an estimated $990K sold.
- MHR Fund Management's largest Q4 2022 buy was Iovance Biotherapeutics: 11,997,103 shares worth $76.7M.
- MHR Fund Management added most to Lions Gate Entertainment Corp. Class A Voting Shares in Q4 2022, an estimated $6.16M increase.
- MHR Fund Management fully exited EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q4 2022, selling an estimated $990K.
- MHR Fund Management's ten largest holdings make up 100% of its $586M portfolio in Q4 2022.
- MHR Fund Management opened 1 new position and closed 12 in Q4 2022.
- MHR Fund Management's portfolio value rose 10% quarter-over-quarter to $586M.
Based on MHR Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.